Hostname: page-component-84b7d79bbc-dwq4g Total loading time: 0 Render date: 2024-08-02T04:21:10.105Z Has data issue: false hasContentIssue false
  • English
  • Français

Essential fatty acids supplements for uncomplicated pregnancy

Published online by Cambridge University Press:  11 September 2013

Get access

In a nutshell

LCPFA are important in pregnancy, and the foetal status may become compromised in certain circumstances.

There is evidence of a modest lengthening of pregnancy duration when LCPFA supplements are given to pregnant women with initially normal pregnancies, but as yet not enough reason to warrant any LCPFA supplement recommendations.

Type
Brief Report
Information
Arbor Clinical Nutrition Updates , Volume 266 , January 2006 , pp. 1 - 3
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Jensen, CL. Effects of n-3 fatty acids during pregnancy and lactation. J Nutr. 2004 Mar;134(3):562–7.Google Scholar
2. Al, MD. et al. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr. 2000 Jan;71(1 Suppl):285S–91S.Google Scholar
3. Makrides, M. et al. Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am J Clin Nutr. 2000 Jan;71(1 Suppl):307S–11S.CrossRefGoogle ScholarPubMed
4. Hornstra, G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr. 2000 May;71(5 Suppl):1262S–9S.Google Scholar
5. Helman, A. Baby formula and infant brain development. Arbor Clin Nutr Upd. 2001(May);91:1–2.Google Scholar
6. Olsen, SF. et al. Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islands and Denmark. Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1203–9.Google Scholar
7. Cetin, I. et al. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. Pediatr Res. 2002 Nov;52(5):750–5.Google Scholar
8. Olafsdottir, AS. et al. Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy. BJOG. 2006 Mar;113(3):301–9.Google Scholar
9. Facchinetti, F. et al. Polyunsaturated fatty acids and risk of preterm delivery. Eur Rev Med Pharmacol Sci. 2005 Jan-Feb;9(1):41–8.Google ScholarPubMed
11. Olsen, SF. et al. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr. 1990 Nov;64(3):599–609.Google Scholar
12. McFadyen, M. et al. Maternal and umbilical cord erythrocyte omega-3 and omega-6 fatty acids and haemorheology in singleton and twin pregnancies. Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F134–8.Google Scholar
13. Helland, IB. et al. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med. 2006 Jul;19(7):397–406.Google Scholar
14. Dunstan, JA. et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr. 2004 Mar;58(3):429–37.Google Scholar
15. Knudsen, VK. et al. Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial. BJOG. 2006 May;113(5):536–43.CrossRefGoogle ScholarPubMed
16. Agostoni, C. et al. Reduced docosahexaenoic acid synthesis may contribute to growth restriction in infants born to mothers who smoke. J Pediatr. 2005 Dec;147(6):854–6.Google Scholar
17. Herrera, JA. et al. Calcium plus linoleic acid therapy for pregnancy-induced hypertension. Int J Gynaecol Obstet. 2005 Dec;91(3):221–7.Google Scholar
18. Salzano, P. et al. [Prevention of gestational hypertension with calcium, linoleic acid, mono and polyunsaturated fatty acid supplements] Minerva Ginecol. 2001 Aug;53(4):235–8.Google Scholar
19. Cheruku, SR. et al. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr. 2002 Sep;76(3):608–13.Google Scholar
20. Dunstan, JA. et al. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Curr Opin Allergy Clin Immunol. 2005 Jun;5(3):215–21.Google Scholar
21. Denburg, JA. et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res. 2005 Feb;57(2):276–81.CrossRefGoogle ScholarPubMed
22. Dunstan, JA. et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol. 2003 Dec;112(6):1178–84.CrossRefGoogle ScholarPubMed
23. Denomme, J. et al. Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J Nutr. 2005 Feb;135(2):206–11.Google Scholar
24. Akabas, SR. et al. Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1536S–1538S.CrossRefGoogle ScholarPubMed
25. Weiler, H. et al. Maternal and cord blood long-chain polyunsaturated fatty acids are predictive of bone mass at birth in healthy term-born infants. Pediatr Res. 2005 Dec;58(6):1254–8.Google Scholar
26. Park, S. et al. Awareness of fish advisories and mercury exposure in women of childbearing age. J Nutr. 2004 Mar;134(3):562–7.Google Scholar